Literature DB >> 19665479

Smoking, nicotine and neuropsychiatric disorders.

Peter Dome1, Judit Lazary, Miklos Peter Kalapos, Zoltan Rihmer.   

Abstract

Tobacco smoking is an extremely addictive and harmful form of nicotine (NIC) consumption, but unfortunately also the most prevalent. Although disproportionately high frequencies of smoking and its health consequences among psychiatric patients are widely known, the neurobiological background of this epidemiological association is still obscure. The diverse neuroactive effects of NIC and some other major tobacco smoke constituents in the central nervous system may underlie this association. This present paper summarizes the pharmacology of NIC and its receptors (nAChR) based on a systematic review of the literature. The role of the brain's reward system(s) in NIC addiction and the results of functional and structural neuroimaging studies on smoking-related states and behaviors (i.e. dependence, craving, withdrawal) are also discussed. In addition, the epidemiological, neurobiological, and genetic aspects of smoking in several specific neuropsychiatric disorders are reviewed and the clinical relevance of smoking in these disease states addressed. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19665479     DOI: 10.1016/j.neubiorev.2009.07.013

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  67 in total

Review 1.  The role of phytochemicals in the treatment and prevention of dementia.

Authors:  Melanie-Jayne R Howes; Elaine Perry
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

2.  Secondhand smoke exposure and mental health in adults: a meta-analysis of cross-sectional studies.

Authors:  Yan-Ni Zeng; Ya-Min Li
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-12-10       Impact factor: 4.328

3.  Inverted U shaped effect of nicotine on the severity of depressive symptoms: A population-based survey.

Authors:  Ammar W Ashor
Journal:  J Young Pharm       Date:  2013-07-08

Review 4.  Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.

Authors:  Manoranjan S D'Souza; Athina Markou
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

5.  Combined effect of obstructive sleep apnea and chronic smoking on cognitive impairment.

Authors:  Ying Ni Lin; Li Na Zhou; Xiu Juan Zhang; Qing Yun Li; Qiong Wang; Hua Jun Xu
Journal:  Sleep Breath       Date:  2015-04-24       Impact factor: 2.816

6.  Motives and perceptions regarding electronic nicotine delivery systems (ENDS) use among adults with mental health conditions.

Authors:  Claire Adams Spears; Dina M Jones; Scott R Weaver; Terry F Pechacek; Michael P Eriksen
Journal:  Addict Behav       Date:  2018-01-16       Impact factor: 3.913

7.  Cigarette smoking and onset of mood and anxiety disorders.

Authors:  Ramin Mojtabai; Rosa M Crum
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

8.  Smoking and Neuroimaging: A Review.

Authors:  Hedy Kober; Cameron M Deleone
Journal:  Curr Cardiovasc Risk Rep       Date:  2011-12-01

9.  Tobacco nitrosamine N-nitrosonornicotine as inhibitor of neuronal nicotinic acetylcholine receptors.

Authors:  Ariane Nunes-Alves; Arthur A Nery; Henning Ulrich
Journal:  J Mol Neurosci       Date:  2012-07-31       Impact factor: 3.444

10.  A twin study of depression and nicotine dependence: shared liability or causal relationship?

Authors:  Alexis C Edwards; Kenneth S Kendler
Journal:  J Affect Disord       Date:  2012-08-16       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.